3-[[3,5-dichloro-4-(1-methyl-6-oxo-5-propan-2-ylpyridazin-3-yl)oxyanilino]methyl]-4H-1,2,4-oxadiazol-5-one
C17H17Cl2N5O4 — CID 146402570
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[3,5-dichloro-4-(1-methyl-6-oxo-5-propan-2-ylpyridazin-3-yl)oxyanilino]methyl]-4H-1,2,4-oxadiazol-5-one
3-[[3,5-dichloro-4-(1-methyl-6-oxo-5-propan-2-ylpyridazin-3-yl)oxyanilino]methyl]-4H-1,2,4-oxadiazol-5-one (PubChem CID 146402570) has the molecular formula C17H17Cl2N5O4 and a molecular weight of 426.26 g/mol. Its IUPAC name is 3-[[3,5-dichloro-4-(1-methyl-6-oxo-5-propan-2-ylpyridazin-3-yl)oxyanilino]methyl]-4H-1,2,4-oxadiazol-5-one.
Molecular Properties
| Compound Name | 3-[[3,5-dichloro-4-(1-methyl-6-oxo-5-propan-2-ylpyridazin-3-yl)oxyanilino]methyl]-4H-1,2,4-oxadiazol-5-one |
|---|---|
| PubChem CID | 146402570 |
| Molecular Formula | C17H17Cl2N5O4 |
| Molecular Weight | 426.26 g/mol |
| Exact Mass | 425.07 |
| IUPAC Name | 3-[[3,5-dichloro-4-(1-methyl-6-oxo-5-propan-2-ylpyridazin-3-yl)oxyanilino]methyl]-4H-1,2,4-oxadiazol-5-one |
| SMILES | CC(C)c1cc(Oc2c(Cl)cc(NCc3noc(=O)[nH]3)cc2Cl)nn(C)c1=O |
| InChI | InChI=1S/C17H17Cl2N5O4/c1-8(2)10-6-14(22-24(3)16(10)25)27-15-11(18)4-9(5-12(15)19)20-7-13-21-17(26)28-23-13/h4-6,8,20H,7H2,1-3H3,(H,21,23,26) |
| InChIKey | RXOOADSEUCHRBT-UHFFFAOYSA-N |
| XLogP | 3.29 |
| TPSA | 115.04 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 426.26 |
| LogP ≤ 5 | 3.29 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146402570 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.